MUC2 and colitis: It has been reported to ameliorate intestinal inflammation by downregulating the expression of inflammatory mediators, such as pro-inflammatory IL-6, IL-8 and NF-κB [9,10], and enhancing the expression of MUC2, which decreased bacterial adherence to the epithelial cell surface and reduced susceptibility to colitis [11].